查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1873193

全球中心静脉通路装置市场

Central Venous Access Devices
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球中心静脉通路装置市场预计2030年将达24亿美元

全球中心静脉通路装置市场规模在2024年估计为18亿美元，预计到2030年将达到24亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为4.8%。本报告分析的细分市场之一—药物输注应用，预计将以5.0%的复合年增长率成长，并在分析期间结束时达到10亿美元。输液和营养输注应用细分市场预计在分析期间内将以5.1%的复合年增长率成长。

美国市场规模估计为4.784亿美元，而中国市场预计将以7.4%的复合年增长率成长。

预计2024年，美国中心静脉通路装置市场规模将达到4.784亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到5.355亿美元，在2024年至2030年的分析期内，复合年增长率（CAGR）将达到7.4%。其他值得关注的区域市场分析包括日本和加拿大，预计在分析期间内，这两个国家的复合年增长率分别为2.9%和3.8%。在欧洲，德国预计将以约3.4%的复合年增长率成长。

全球中心静脉通路装置市场－主要市场趋势与驱动因素概述

为什么中心静脉通路装置在现代医学中如此重要？

中心静脉通路装置（CVAD）已成为现代医学中不可或缺的一部分，尤其适用于需要长期静脉治疗的患者，例如化疗、透析和肠外营养。这些装置包括插入锁骨下静脉或颈内静脉等大静脉的导管，能够有效且稳定地将药物、液体和其他疗法直接输送到血液中。对于接受癌症治疗的患者，中央静脉导管减少了反覆穿刺的需要，提供了更舒适且方便的解决方案。它们能够输送高浓度药物，同时降低静脉刺激的风险，这在加护治疗环境中尤其重要。如今，中心静脉导管的应用范围已扩展到多种医疗领域，包括慢性病管理、急诊护理和维生治疗，使其成为现代医疗通讯协定中不可或缺的工具。

科技创新如何提高中心静脉导管的安全性和有效性？

技术进步显着改善了中心静脉通路装置的设计和功能，提高了病人安全性和临床疗效。其中一项最显着的创新是抗菌和抗血栓涂层的研发，这有助于降低导管相关感染疾病和血栓的风险，而这些正是中心静脉通路装置最常见的併发症。此外，硅胶和聚氨酯等导管材料的进步使这些装置更加柔韧耐用，最大限度地降低了静脉损伤的风险，并延长了装置的使用寿命。另一项关键创新是在导管插入过程中使用超音波引导，这显着提高了中心静脉通路装置置入的准确性和安全性。该技术降低了动脉穿刺和气胸等插入併发症的风险，同时缩短了手术时间。此外，整合感测器和即时监测功能的装置的研发使医护人员能够更有效地追踪导管功能、检测堵塞并监测患者状况。这些创新使中心静脉导管更安全、更可靠、更易于管理，从而在全球医院和诊所中广泛使用。

市场动态和患者人口统计数据将在中心静脉导管（CVAD）的采用中发挥什么作用？

慢性疾病（尤其是癌症和肾衰竭）盛行率的不断上升是推动中心静脉通路装置需求成长的主要因素之一。随着全球人口老化，需要长期静脉治疗的疾病发生率持续上升，使得中心静脉通路装置成为现代医疗保健的重要组成部分。例如，在肿瘤领域，癌症诊断率的上升导致中心静脉通路装置在化疗和其他标靶治疗中的应用相应增加。同样，末期肾功能衰竭患者需要透析治疗的人数不断增加，也推动了中央静脉导管作为关键治疗网路基地台的使用。除了慢性疾病，中心静脉通路装置在急诊护理中也越来越多地用于快速输注液体、血液製品和救命药物。在市场动态方面，先进导管产品的日益普及（尤其是在新兴市场）以及医疗基础设施的不断完善，也促进了中心静脉通路装置的广泛应用。对微创治疗方法的需求，加上病患治疗效果的改善，进一步加速了这些装置在各种医疗保健环境中的应用。

中心静脉通路装置市场的成长要素是什么？

中心静脉通路装置市场的成长受到多种因素的驱动，这些因素与不断变化的医疗需求和技术进步密切相关。癌症、慢性肾臟病和其他需要静脉输液治疗的长期疾病的日益普遍是主要驱动因素。随着越来越多的患者接受化疗、透析和肠外营养等长期治疗，对中心静脉通路装置的需求也随之飙升。导管设计的技术进步，特别是抗菌涂层和抗血栓装置的研发，使这些装置更加安全耐用，从而促进了其在医院和诊所的应用。此外，超音波引导导管插入技术的广泛应用，帮助医护人员更精准地放置这些装置，从而减少併发症并改善患者预后。另一个关键驱动因素是对微创和长期治疗方案的需求不断增长，尤其是老年患者和慢性疾病患者。各国政府和医疗机构也积极推动更安全、更有效的医疗设备的应用，这进一步促进了先进中心静脉通路装置市场的扩张。此外，发展中地区医疗基础设施的不断完善以及人们对中心静脉通路装置益处的认识不断提高，都促进了市场成长。这些因素，加上对加强感染控制和提高患者舒适度的需求，共同推动了全球中心静脉通路装置市场的快速扩张。

部分：

透过应用（药物给药、液体和营养支持、输血、诊断和检测）

受访公司范例

  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • B. Braun Medical Ltd.
  • BARD, A Becton, Dickinson Company
  • Medical Components, Inc.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Teleflex Inc.
  • Vygon SA

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，革新市场和竞争情报分析。

Global Industry Analysts 并没有依赖通用的 LLM 或查询产业专用的SLM，而是建立了一个由世界各地领域专家精心整理的内容库，包括视讯转录、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

我们最新发布的报告纳入了关税对区域市场的影响，正如全球产业分析师预测的那样，关税将改变企业的竞争地位，而企业的竞争地位将取决于其总部所在地、製造地以及进出口（成品和OEM产品）。这种复杂多变的市场现实将透过微观和宏观市场动态影响竞争对手，包括销货成本增加、盈利下降以及供应链重组。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 亚太其他地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP10962

Global Central Venous Access Devices Market to Reach US$2.4 Billion by 2030

The global market for Central Venous Access Devices estimated at US$1.8 Billion in the year 2024, is expected to reach US$2.4 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Drug Administration Application, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$1.0 Billion by the end of the analysis period. Growth in the Fluid & Nutrition Administration Application segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$478.4 Million While China is Forecast to Grow at 7.4% CAGR

The Central Venous Access Devices market in the U.S. is estimated at US$478.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$535.5 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Central Venous Access Devices Market - Key Trends and Drivers Summarized

Why Are Central Venous Access Devices Crucial in Modern Medical Treatments?

Central Venous Access Devices (CVADs) have become indispensable in modern healthcare, especially for patients requiring long-term intravenous treatments, such as chemotherapy, dialysis, or parenteral nutrition. These devices, which include catheters inserted into large veins like the subclavian or jugular vein, allow for the efficient and consistent delivery of medications, fluids, and other therapies directly into the bloodstream. For patients undergoing cancer treatments, central venous catheters reduce the need for repeated needle insertions, offering a less painful and more convenient solution. The ability to administer high concentrations of medication while reducing the risk of vein irritation makes CVADs particularly valuable in intensive care settings. Their usage has expanded across a variety of medical applications, including the management of chronic diseases, emergency care, and the administration of life-saving treatments, making CVADs an essential tool in modern medical protocols.

How Are Technological Innovations Improving the Safety and Efficiency of CVADs?

Technological advancements have significantly improved the design and functionality of Central Venous Access Devices, enhancing both patient safety and clinical outcomes. One of the most notable innovations is the development of antimicrobial and anti-thrombogenic coatings, which help reduce the risks of catheter-related infections and blood clots, two of the most common complications associated with CVADs. Additionally, advancements in catheter materials, such as silicone and polyurethane, have made these devices more flexible and durable, minimizing the risk of vein damage and ensuring longer device lifespan. Another key innovation is the use of ultrasound guidance for catheter insertion, which has greatly improved the accuracy and safety of CVAD placement. This technology reduces the risk of complications during insertion, such as puncturing arteries or causing pneumothorax, while also shortening the procedure time. Furthermore, the development of devices with integrated sensors and real-time monitoring capabilities has enhanced the ability of healthcare providers to track catheter function, detect blockages, and monitor patient conditions more effectively. These innovations are making CVADs safer, more reliable, and easier to manage, driving their adoption in hospitals and clinics worldwide.

What Role Do Market Dynamics and Patient Demographics Play in CVAD Adoption?

The increasing prevalence of chronic diseases, particularly cancer and renal failure, is one of the key factors driving the growing demand for Central Venous Access Devices. As the global population ages, the incidence of conditions requiring long-term intravenous therapy continues to rise, making CVADs an essential component of modern medical care. In oncology, for instance, the rising number of cancer diagnoses has led to a corresponding increase in the use of CVADs for the administration of chemotherapy and other targeted therapies. Similarly, the growing number of patients requiring dialysis due to end-stage renal disease has driven the use of central venous catheters as a critical access point for treatment. In addition to chronic diseases, CVADs are increasingly used in emergency care settings for the rapid administration of fluids, blood products, and life-saving medications. Market dynamics, including the increasing availability of advanced catheter products and improved healthcare infrastructure, particularly in emerging markets, are also contributing to the rise in CVAD adoption. The demand for minimally invasive treatment options, coupled with improved patient outcomes, is further accelerating the use of these devices across a range of healthcare settings.

What Are the Factors Behind the Growth of Central Venous Access Devices Market?

The growth of the Central Venous Access Devices market is driven by several factors related to evolving medical needs and technological advancements. The rising prevalence of cancer, chronic kidney disease, and other long-term conditions that require intravenous therapies is a significant driver. With more patients undergoing extended treatments like chemotherapy, dialysis, and parenteral nutrition, the demand for CVADs has surged. Technological advancements in catheter design, particularly the development of antimicrobial-coated and anti-thrombogenic devices, have made these devices safer and more durable, driving their adoption across hospitals and clinics. In addition, the increased use of ultrasound-guided catheter insertion techniques has made it easier for healthcare providers to place these devices with higher accuracy, reducing complications and improving patient outcomes. Another major factor is the growing demand for minimally invasive and long-term treatment solutions, particularly among elderly patients and those with chronic conditions. Governments and healthcare providers are also pushing for the adoption of safer, more effective medical devices, further boosting the market for advanced CVADs. Moreover, the expanding healthcare infrastructure in developing regions, along with the increasing awareness of the benefits of CVADs, is contributing to market growth. These factors, combined with the need for better infection control and patient comfort, are fueling the rapid expansion of the global Central Venous Access Devices market.

SCOPE OF STUDY:

The report analyzes the Central Venous Access Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Drug Administration, Fluid & Nutrition Administration, Blood Transfusion, Diagnostics & Testing)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • B. Braun Medical Ltd.
  • BARD, A Becton, Dickinson Company
  • Medical Components, Inc.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Teleflex Inc.
  • Vygon SA

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Central Venous Access Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Chronic Diseases Propels Growth of Central Venous Access Devices Market
    • Increasing Use of Central Venous Catheters in Chemotherapy Expands Addressable Market for Venous Access Devices
    • Technological Advancements in Catheter Materials Strengthen Business Case for Safer and Longer-Lasting Devices
    • Rising Geriatric Population Spurs Demand for Central Venous Access Devices in Long-Term Care
    • Advancements in Infection Control Technologies Propel Growth in Central Venous Access Devices with Antimicrobial Properties
    • Increasing Use of Central Venous Access Devices in Dialysis and Critical Care Sustains Market Growth
    • Growing Focus on Home Healthcare Throws the Spotlight on Portable and Easy-to-Use Central Venous Access Devices
    • Rising Adoption of Ultrasound-Guided Catheter Insertion Accelerates Demand for Specialized Central Venous Access Devices
    • Increasing Use of Central Venous Access Devices in Pediatric Care Expands Market Potential
    • Focus on Reducing Catheter-Related Complications Strengthens Demand for Advanced Venous Access Devices
    • Rising Prevalence of Cancer and the Need for Long-Term IV Therapies Spur Growth in Central Venous Access Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Central Venous Access Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Central Venous Access Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Central Venous Access Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Central Venous Access Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Drug Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Drug Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Drug Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Fluid & Nutrition Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Fluid & Nutrition Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Fluid & Nutrition Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Blood Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Blood Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Blood Transfusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostics & Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostics & Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostics & Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Canada 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • JAPAN
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Japan 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • CHINA
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: China 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • EUROPE
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Central Venous Access Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Central Venous Access Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Central Venous Access Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • FRANCE
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: France 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • GERMANY
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Germany 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Italy 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: UK 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Spain 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Russia 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Rest of Europe 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Access Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Central Venous Access Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Central Venous Access Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Australia 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • INDIA
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: India 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: South Korea 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Central Venous Access Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Central Venous Access Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Central Venous Access Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Argentina 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Brazil 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Mexico 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Latin America 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Central Venous Access Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Central Venous Access Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Central Venous Access Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Iran 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Israel 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Saudi Arabia 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UAE 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Middle East 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • AFRICA
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Africa 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030

IV. COMPETITION